Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 639489, 6 pages
http://dx.doi.org/10.1155/2014/639489
Clinical Study

Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume 830-0011, Japan
2Municipal Yame General Hospital, Yame 834-0034, Japan
3Kouhoukai Takagi Hospital, Okawa 831-0016, Japan
4Inada Clinic, Kurume 830-0039, Japan
5Shimada Hospital, Ogori 838-0141, Japan
6Tenjinkai Koga Hospital 21, Kurume 839-0801, Japan
7Saint Mary Hospital, Kurume 830-8543, Japan
8Tenjinkai Shin-Koga Hospital, Kurume 830-8577, Japan

Received 10 March 2014; Accepted 5 June 2014; Published 3 August 2014

Academic Editor: Qi Zhang

Copyright © 2014 Yuji Tajiri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yuji Tajiri, Seiko Kawano, Saori Hirao, et al., “Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes,” International Scholarly Research Notices, vol. 2014, Article ID 639489, 6 pages, 2014. doi:10.1155/2014/639489